Therapeutic angiogenesis for heart failure

被引：103

作者：

Isner, JM ^{[1
]}

Losordo, DW

机构：

[1] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Dept Med Cardiol Vasc Med, Boston, MA 02111 USA

[2] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Dept Biomed Res, Boston, MA 02111 USA

[3] St Elizabeths Med Ctr, Boston, MA 02135 USA

来源：

NATURE MEDICINE | 1999年 / 5卷 / 05期

关键词：

D O I：

10.1038/8374

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A new study answers one set of questions, but raises many more, about the potential use of specific VEGF isoforms to promote re-vascularization for ischemic cardiomyopathy (pages 495-502).

引用

页码：491 / 492

页数：2

共 14 条

[1] Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].

Baumgartner, I ;

Pieczek, A ;

Manor, O ;

Blair, R ;

Kearney, M ;

Walsh, K ;

Isner, JM .

CIRCULATION, 1998, 97 (12) :1114-1123

[2] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].

Carmeliet, P ;

Ferreira, V ;

Breier, G ;

Pollefeyt, S ;

Kieckens, L ;

Gertsenstein, M ;

Fahrig, M ;

Vandenhoeck, A ;

Harpal, K ;

Eberhardt, C ;

Declercq, C ;

Pawling, J ;

Moons, L ;

Collen, D ;

Risau, W ;

Nagy, A .

NATURE, 1996, 380 (6573) :435-439

[3] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].

Ferrara, N ;

CarverMoore, K ;

Chen, H ;

Dowd, M ;

Lu, L ;

OShea, KS ;

PowellBraxton, L ;

Hillan, KJ ;

Moore, MW .

NATURE, 1996, 380 (6573) :439-442

[4] VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts [J].

Hariawala, MD ;

Horowitz, JR ;

Esakof, D ;

Sheriff, DD ;

Walter, D ;

Keyt, B ;

Isner, JM ;

Symes, JF .

JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) :77-82

[5]

HOUCK KA, 1992, J BIOL CHEM, V267, P26031

[6] Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].

Isner, JM ;

Pieczek, A ;

Schainfeld, R ;

Blair, R ;

Haley, L ;

Asahara, T ;

Rosenfield, K ;

Razvi, S ;

Walsh, E ;

Symes, JF .

LANCET, 1996, 348 (9024) :370-374

[7] Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results [J].

Isner, JM ;

Baumgartner, I ;

Rauh, G ;

Schainfeld, R ;

Blair, R ;

Manor, O ;

Razvi, S ;

Symes, JF .

JOURNAL OF VASCULAR SURGERY, 1998, 28 (06) :964-973

[8] Gene therapy for myocardial angiogenesis -: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia [J].

Losordo, DW ;

Vale, PR ;

Symes, JF ;

Dunnington, CH ;

Esakof, DD ;

Maysky, M ;

Ashare, AB ;

Lathi, K ;

Isner, JM .

CIRCULATION, 1998, 98 (25) :2800-2804

[9] Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart [J].

Mack, CA ;

Patel, SR ;

Schwarz, EA ;

Zanzonico, P ;

Hahn, RT ;

Ilercil, A ;

Devereux, RB ;

Goldsmith, SJ ;

Christian, TF ;

Sanborn, TA ;

Kovesdi, I ;

Hackett, N ;

Isom, OW ;

Crystal, RG ;

Rosengart, TK .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (01) :168-176

[10] MAGNETIC-RESONANCE MAPPING DEMONSTRATES BENEFITS OF VEGF INDUCED MYOCARDIAL ANGIOGENESIS [J].

PEARLMAN, JD ;

HIBBERD, MG ;

CHUANG, ML ;

HARADA, K ;

LOPEZ, JJ ;

GLADSTONE, SR ;

FRIEDMAN, M ;

SELLKE, FW ;

SIMONS, M .

NATURE MEDICINE, 1995, 1 (10) :1085-1089

← 1 2 →